Is the Cleveland Clinic currently conducting a clinical study on the effects of injecting VEGF growth hormone directly into the heart muscle to generate new arteries? If so, what is the criteria for entering the study and how would i apply?
--------------------------------------------------------------------------------------------------------------------
Dear Edward,
Thank you for your question. Unfortunately we do not currently have a DNA trial underway here. We have had one in the past with Dr. Stephen
EllisEllis tonic sherry. It was called the VEGEF trial and involved the direct application of DNA to diseased coronary arteries. The inclusion requirements were as follows: 1. At least 20% reversible
ischemiaHepatic ischemia
Ischemic colitis
Mesenteric artery ischemia
Testicular torsion
Vertebrobasilar circulatory disorders on PET or
thalliumThallium and sestamibi stress tests scan. 2. Heart cath within the last 6 months. 3. No cancer. 4. No
retinopathyDiabetic retinopathy
Retinopathy of prematurity (eye
disorderAdjustment disorder
Anorexia nervosa
Asperger syndrome
Autism
Autoimmune disorders
Bipolar disorder
Bipolar disorder
Bleeding disorders
Borderline personality disorder
Bulimia
Chronic motor tic disorder). 5. Ejection fraction of at least 25%.
If you would like to be considered for future trials or you have additional questions contact Cathy Comella at (216) 444-0053.
I hope you find this information useful. Information provided in the heart forum is for general purposes only. Only your physician can provide specific diagnoses and therapies. Please feel free to write back with additional questions.
If you would like to make an appointment at the Cleveland Clinic Heart Center, please call 1-800-CCF-CARE or inquire online by using the Heart Center website at www.ccf.org/heartcenter. The Heart Center website contains a directory of the cardiology staff that can be used to
selectSelect-ob
Select-ob+dha the physician best suited to address your cardiac problem.